TP53 and nasopharyngeal carcinoma: Importantly, blocking of PI3K-Akt signaling pathway abolished heterozygous p53-R280T mutation-promoting NPC cell proliferation and survival, indicating that heterozygous p53-R280T mutation promotes the oncogenicity of NPC cells by activating PI3K-Akt signaling pathway.